We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
-2.85%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$13.2B
AUM Growth
-$412M
Cap. Flow
+$22.7M
Cap. Flow %
0.17%
Top 10 Hldgs %
19.23%
Holding
1,105
New
52
Increased
451
Reduced
454
Closed
55

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$69.2M
2
BUD icon
AB InBev
BUD
+$66.1M
3
AMD icon
Advanced Micro Devices
AMD
+$50.8M
4
ALL icon
Allstate
ALL
+$49.4M
5
NVDA icon
NVIDIA
NVDA
+$47.1M

Sector Composition

Rank Sector Weight
1 Financials 17.82%
2 Technology 13.78%
3 Healthcare 11.11%
4 Consumer Discretionary 9.49%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIV icon
1026
Telefônica Brasil
VIV
$20.6B
$125K ﹤0.01%
14,608
-3,144
-18% -$27.3K
XRN
1027
Chiron Real Estate Inc
XRN
$514M
$124K ﹤0.01%
2,770
PFLT icon
1028
PennantPark Floating Rate Capital
PFLT
$689M
$122K ﹤0.01%
11,400
KYN icon
1029
Kayne Anderson Energy Infrastructure Fund
KYN
$2.47B
$115K ﹤0.01%
13,726
-2,304
-14% -$19.9K
PML
1030
PIMCO Municipal Income Fund II
PML
$485M
$108K ﹤0.01%
14,058
-3,162
-18% -$27.6K
RMT
1031
Royce Micro-Cap Trust
RMT
$728M
$105K ﹤0.01%
12,697
+85
+0.7% +$749
JPC icon
1032
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$87.4K ﹤0.01%
13,805
EGHT icon
1033
8x8 Inc
EGHT
$269M
$76K ﹤0.01%
30,167
-1,265
-4% -$4.5K
IGR
1034
CBRE Global Real Estate Income Fund
IGR
$709M
$75.3K ﹤0.01%
16,723
MPT
1035
Medical Properties Trust
MPT
$2.77B
$61K ﹤0.01%
11,196
-1,586
-12% -$12.7K
VVR icon
1036
Invesco Senior Income Trust
VVR
$457M
$59.6K ﹤0.01%
15,200
LYG icon
1037
Lloyds Banking Group
LYG
$89.5B
$42.9K ﹤0.01%
+20,160
New +$43.7K
CIK
1038
Credit Suisse Asset Management Income Fund
CIK
$134M
$37.6K ﹤0.01%
14,500
DRRX
1039
DELISTED
DURECT Corp
DRRX
$37.4K ﹤0.01%
15,000
-1,000
-6% -$3.41K
CGC
1040
Canopy Growth
CGC
$387M
$32.7K ﹤0.01%
4,208
SGMO
1041
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$28.3K ﹤0.01%
47,100
-21,200
-31% -$22.7K
SEEL
1042
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$26.8K ﹤0.01%
38
+3
+9% +$12.9K
ANGI icon
1043
Angi Inc
ANGI
$229M
$26.5K ﹤0.01%
+1,340
New +$38.3K
SMSI icon
1044
Smith Micro Software
SMSI
$14.5M
$12.1K ﹤0.01%
250
CELG.RT
1045
Bristol-Myers Squibb Rights
CELG.RT
$191M
$8.64K ﹤0.01%
90,970
CONXW
1046
DELISTED
CONX Corp. Warrant
CONXW
$1.95K ﹤0.01%
13,000
SEEL
1047
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$1.84K ﹤0.01%
+3
New +$12.9K
HOFVW
1048
DELISTED
Hall of Fame Resort & Entertainment Company Warrant
HOFVW
$275 ﹤0.01%
13,333
AAP icon
1049
Advance Auto Parts
AAP
$3.35B
-5,126
Closed -$360K
AEM icon
1050
Agnico Eagle Mines
AEM
$73.6B
-8,649
Closed -$432K

Similar funds

Davenport & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Davenport & Co held 1,105 positions worth $13.2B, down 3% from $13.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Davenport & Co's Q3 2023 filing shows 52 new, 451 increased, 454 reduced and 55 closed positions. Its largest new stake was Kenvue: 1,035,174 shares worth $20.8M. The largest sale was Pioneer Natural Resource Co., an estimated $82.7M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Davenport & Co's largest Q3 2023 buy was Kenvue: 1,035,174 shares worth $20.8M.
  • Davenport & Co added most to Walt Disney in Q3 2023, an estimated $69.2M increase.
  • Davenport & Co's biggest Q3 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $82.7M.
  • Davenport & Co fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $57.3M.
  • Davenport & Co's ten largest holdings make up 19% of its $13.2B portfolio in Q3 2023.
  • Davenport & Co opened 52 new positions and closed 55 in Q3 2023.
  • Davenport & Co's portfolio value fell 3% quarter-over-quarter to $13.2B.

Based on Davenport & Co's 13F filing for Q3 2023, filed 17 Oct 2023.